Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...

Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsMatthew Kreps - Investor RelationsLawrence Firestone ...

Q3 2025 Earnings Call Transcript November 4, 2025 22nd Century Group, Inc. beats earnings expectations. Reported EPS is $0.4617, expectations were $-16.79. Operator: Welcome to 22nd Century Group’s ...

Net income and earnings per share ("EPS")* were $19.4 million and $0.82, respectively, for the third quarter of 2025 and $94.2 million and $4.03, respectively, ...